AVP and type 2 diabetes mellitus: In line with our study, Velho et al.25 investigated individuals with type 1 or type 2 diabetes as well as in the healthy controls and they found that plasma copeptin was linked to perturbations in eGFR, as well as to the impairment in kidney function and the progression of DN during follow-up in both cohorts.